Immuno-Biological Laboratories Co., Ltd.
Status: Publicly traded
Direct answer
Immuno-Biological Laboratories Co., Ltd. is publicly traded on JPX under the ticker 4570.T.
Immuno-Biological Laboratories Co., Ltd. (IBL) is a global entity dedicated to the research, development, production, and distribution of immunological reagents. The company's diverse offerings include ELISA assay kits designed for the precise quantitative measurement of targeted substances, alongside comprehensive research support services focusing on areas such as Alzheimer's disease, metabolic syndrome, and...
Can you invest in Immuno-Biological Laboratories Co., Ltd.?
Yes. Immuno-Biological Laboratories Co., Ltd. is publicly traded on JPX under the ticker 4570.T.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Immuno-Biological Laboratories Co., Ltd.
Detailed equity research is provided by MarketSnap.